Advertisement
Hepatitis C may increase the risk for certain types of head and neck cancers

Hepatitis C Found to Up Odds for Certain Head and Neck Cancers

0
Researcher sees need for improved screening, treatment
Zika virus is a definite and direct cause of microcephaly and other brain-related birth defects

CDC: Zika Link to Microcephaly, Brain Damage Confirmed

0
Evidence confirms infection during early pregnancy leads to severe form of microcephaly
Staff at many outpatient health care facilities in New Mexico failed to follow recommendations for hand hygiene more than one-third of the time

Health Care Workers Skip Hand Washing One-Third of the Time

0
Outpatient facility staff also found to be lacking at safe injection practices
The offspring of women using ondansetron early in pregnancy for nausea and vomiting of pregnancy or hyperemesis gravidarum may be at risk for cardiac abnormalities

Review: Low Risk of Birth Defects With Ondansetron Exposure

0
Ondansetron-exposed neonates may have small increase in incidence of cardiac abnormalities
A timed in vitro prion protein conversion protocol is sensitive for detecting elk chronic wasting disease in brain tissues

New Assay May Help Improve Detection of Prion Diseases

0
Assay as sensitive for elk chronic wasting disease as two bioassay models, more sensitive than rapid test
People with high intake of fast food may have levels of phthalates in their urine that are 24 to 40 percent higher than people who rarely eat fast food

Consumption of Fast Food Linked to Greater Exposure to Phthalates

0
High consumption linked to higher urinary levels of di(2-ethylhexyl) phthalate, diisononyl phthalate
Despite an increased proportion of Bordetella pertussis isolates lacking pertactin

Efficacy of DTaP, Tdap Holds Despite Pertactin Deficiency

0
Similar estimates for DTaP, Tdap VE to other settings, despite high prevalence of pertactin deficiency
There has been an increase in the number of patients being treated for Galactose-alpha-1

Increase in Number of Patients Being Treated for Alpha-Gal

0
Increase attributed to improved understanding of presentation, and improved diagnostic testing
There are no significant differences in occurrence of cardiovascular disease tied to treatment with glucagon-like peptide-1 receptor agonists compared with dipeptidyl peptidase-4 inhibitors

CV Risk Not Significantly Different for GLP-1 Receptor Agonists

0
Findings based on large study in real-world, head-to-head comparison of other drugs
Use of the word "breakthrough" in the U.S. Food and Drug Administration's expedited approval process could mislead doctors about the new drugs' actual benefits

Doctors Can Be Misled About FDA ‘Breakthrough’ Drug Designation

0
Many believe meds supported by stronger evidence than the law requires to achieve designation